Literature DB >> 20812968

Modulation of metallothionein isoforms is associated with collagen deposition in proliferating keloid fibroblasts in vitro.

Pearl P-C Toh1, Jasmine J Li, George W-C Yip, Soo-Ling Lo, Chun-Hua Guo, Toan-Thang Phan, Boon-Huat Bay.   

Abstract

The keloid fibroblast (KF) is known to have higher proliferative capacity than normal dermal fibroblast (NF). Metallothionein (MT), a metal-binding protein, has been reported to promote cell proliferation. In this study, we evaluated the expression of MT isoforms at the mRNA level in fetal bovine serum (FBS)-stimulated proliferating KF. Although the morphological appearance of NF and KF was similar when viewed under light, confocal and transmission electron microscopy, there was surprisingly a generally lower expression of MT isoforms in KF when compared with NF and also reduced MT staining in dermal fibroblasts of keloids as opposed to normal skin. Primary cultures of KF grown in 5% FBS or 10% FBS compared to without FBS demonstrated significantly higher proliferative activity and more abundant deposition of collagen. Contrary to expectation, MT-1A, -1F, -1G, -1X and -2A isoforms were significantly down-regulated in proliferating KF. Moreover, stimulating KF with TGF β1, which is known to promote collagen synthesis and keloid formation, increased expression of Collagen 1A and 3A genes accompanied by reduction in MT-2A gene expression. Furthermore, down-regulation of the MT-2A gene in proliferating KF by siRNA-mediated silencing enhanced cell proliferation with concomitant up-regulation of the NF-κB gene and 10 of 13 other NF-κB pathway-related genes analysed but no alteration of the Collagen 1 and Collagen 3 gene expression. It would appear that down-regulation of MT isoforms in proliferating KF, in particular MT-2A, enhances keloidogenesis with the possible involvement of the NF-κB signalling pathway.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812968     DOI: 10.1111/j.1600-0625.2010.01124.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  6 in total

1.  Effect of collagen nanotopography on keloid fibroblast proliferation and matrix synthesis: implications for dermal wound healing.

Authors:  Lalitha Muthusubramaniam; Tatiana Zaitseva; Michael Paukshto; George Martin; Tejal Desai
Journal:  Tissue Eng Part A       Date:  2014-05-20       Impact factor: 3.845

2.  Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism.

Authors:  Huashan Liu; Zhenxing Liang; Fengwei Wang; Chi Zhou; Xiaobin Zheng; Tuo Hu; Xiaowen He; Xianrui Wu; Ping Lan
Journal:  JCI Insight       Date:  2019-12-19

3.  Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression.

Authors:  Qing Chun; Wang ZhiYong; Song Fei; Wang XiQiao
Journal:  Int Wound J       Date:  2014-05-07       Impact factor: 3.315

4.  A bioengineered living cell construct activates metallothionein/zinc/MMP8 and inhibits TGFβ to stimulate remodeling of fibrotic venous leg ulcers.

Authors:  Rivka C Stone; Olivera Stojadinovic; Andrew P Sawaya; George D Glinos; Linsey E Lindley; Irena Pastar; Evangelos Badiavas; Marjana Tomic-Canic
Journal:  Wound Repair Regen       Date:  2019-12-04       Impact factor: 3.617

5.  Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse.

Authors:  Masataka Tsuge; Yoshifumi Fujimoto; Nobuhiko Hiraga; Yizhou Zhang; Mayu Ohnishi; Tomohiko Kohno; Hiromi Abe; Daiki Miki; Michio Imamura; Shoichi Takahashi; Hidenori Ochi; C Nelson Hayes; Fuyuki Miya; Tatsuhiko Tsunoda; Kazuaki Chayama
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

6.  Bioinformatics study on different gene expression profiles of fibroblasts and vascular endothelial cells in keloids.

Authors:  Weihan Zheng; Guojian Lin; Zhizhou Wang
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.